[A clinical study of estramustine phosphate sodium for the treatment of hot flushes in men with prostate cancer]
- PMID: 15508700
- DOI: 10.5980/jpnjurol1989.95.761
[A clinical study of estramustine phosphate sodium for the treatment of hot flushes in men with prostate cancer]
Abstract
Purpose: To assess the effectiveness and tolerability of estramustine sodium phosphate in men with hot flushes during combined androgen blockade (CAB) therapy for prostate cancer.
Patients and methods: Seven men with moderate to severe hot flushes were received estramustine sodium phosphate. Treatment response was assessed by hot flush score.
Results: A significant reduction in the hot flush score was seen with all patients. No thromboembolic complications occurred in any patients.
Conclusions: Estramustine sodium phosphate appears to be a promising, well-tolerated and useful therapy for men with hot flushes during CAB treatment for prostate cancer.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources